IR

Isabel Amat Riera

Co Founder at MANREMYC, S.L.

Isabel Amat Riera has a strong background in the pharmaceutical industry and innovation management. Isabel started their career at Archivel Farma in 2005, where they served as the Chief Pharmaceutical Developer Officer for eight years. In 2010, they joined Reig Jofre as the Global Head of Innovation and Pipeline Management. In 2013, they co-founded MANREMYC, S.L. Later, in 2017, they became a mentor for IQS Tech Factory's Next Tech Acceleration Program. In 2018, they joined Syna Therapeutics and CataloniaBio & HealthTech as a member of their boards. Throughout their career, Isabel has consistently demonstrated their expertise in pharmaceutical development, innovation, and leadership.

Isabel Amat Riera has a Bachelor Degree in Chemistry from the Universitat de Barcelona. Isabel also holds a MSc Master's in Innovation and Entrepreneurship from Esade. Additionally, they have completed a PDD degree from the IESE Business School. The dates of enrollment and completion of these programs are not provided.

Location

Barcelona, Spain

Links


Org chart


Teams

This person is not in any teams


Offices


MANREMYC, S.L.

MANREMYC is a “spin off” of the Institut for Biomedical Research Germans Trias i Pujol (IGTP) with the mission to eradicate tuberculosis (TB) by reducing its risk of development with a unique and revolutionary product, Nyaditum resae® (NR) based on the most updated technology and a solid scientific background.


Headquarters

Manresa, Spain

Employees

1-10

Links